Integrating ethical enquiry and health technology assessment: limits and opportunities for efficiency and equity
Tóm tắt
Từ khóa
Tài liệu tham khảo
Adams ME, McCall NT, Gray DT, Orza MJ, Chalmers TC (1992) Economic analysis in randomised control trials. Med Care 30:231–243
Australia Commonwealth Department of Health, Housing and Community Services (1992) Guidelines for the pharmaceutical industry on preparation of submissions to the Pharmaceutical Benefits Advisory Committee. Commonwealth Department, Canberra
Backhouse ME, Backhouse RJ, Eddy SA (1992) Economic evaluation bibliography. Health Econ 1(supplement):s1–s236
Birch S, Donaldson C (1987) Applications of cost-benefit analysis to health care. J Health Econ 6:211–225
Boyd NF, Sutherland HJ, Heasman KZ et al. (1990) Whose utilities for decision analysis? Med Decis Making 10:58–67
Bradshaw J (1972) The concept of social need. New Soc 30
Briggs A, Sculpher M (1995) Sensitivity analysis in economic studies: a review of published studies. Health Econ 4:355–371
Briggs A, Sculpher M, Buxton M (1994) Uncertainty in the economic evaluation of health care technologies: the role of sensitivity analysis. Health Econ 3:95–104
British Medical Journal (1996) Working party on economic evaluation. Guidelines for authors and peer reviewers of economic submissions to the British Medical Journal. Brit Med J 313:275–283
Buxton M, Ashby J (1988) The time trade-off approach to health state valuation. Teeling A, Smith G (eds) Measuring health: a practical approach. Wiley, Chichester, p 69–87
CCOHTA—Canadian Co-ordinating Office for Health Technology Assessment (1994) Guidelines for economic evaluation of pharmaceuticals: Canada. CCOHTA, Ottawa
Culyer A, Wagstaff A (1991) Need, equality and social justice. Discussion Paper 90, Centre for Health Economics, York University, York
Detsky AS, Naglie IG (1990) A clinician’s guide to cost-effectiveness analysis. Ann Intern Med 113:147–154
Drummond MF, O’Brien B, Stoddart GL, Torrance GW (1997) Methods for the Economic Evaluation of Health Care Programmes, 2nd edn. Oxford University Press, New York
Drummond M, Brandt A, Luce B, Rovira J (1993) Standardising methodologies for economic evaluation in health care. Practice, problems, and potential. Int J Technol Assess 9:26–36
Drummond MF, Davies L (1991) Economic analysis alongside clinical trials: revisited the methodological issues. Int J Technol Assess 7:561–573
Dworkin DR (1981) What is equality? Part 1: equality of welfare; Part 2: equality of resources. Philos Public Aff 10:185–247, 283–345
Eddy DM (1992) A manual for assessing health practices & designing practice policies. The explicit approach. American College of Physicians, Philadelphia, PA
Eisenberg JM (1989) Clinical economics: a guide to the economic analysis of clinical practices. J Amer Med Assoc 262:2879–2886
Elixhauser (ed) (1993) Health care cost-benefit and cost effectiveness analysis (CBA\CEA) from 1979 to 1990: a bibliography. Med Care 31:1–236
England and Wales Department of Health (1994) Guidelines on good practice in the conduct of economic evaluation of medicines. Department of Health, London
Evans RG (1995) Manufacturing consensus, marketing truth: guidelines for economic evaluation. Ann Intern Med 123:59–60
Flemming TR, DeMets DL (1996) Surrogate end points in clinical trials: are we being misled? Ann Intern Med 125:605–613
Fox J (ed) (1989) Health inequalities in European Countries. Gower
Gafni A, Birch S (1995) Preferences for outcomes in economic evaluation: an economic approach to addressing economic problems. Soc Sci Med 40:767–776
Gafni A, Birch S (1995) Preferences for outcomes in economic evaluation: an economic approach to addressing economic problems. Soc Sci Med 40:767–776
Garattini L, Grilli R, Scopelliti D, Mantovani L (1995) A proposal for Italian guidelines in pharmacoeconomics. Pharmacoeconomics 7:1–6
Gold MR, Siegel JE, Russell LB, Weinstein MC (1996) Cost-effectiveness in health and medicine. Oxford University Press, New York
Goodman A, Craig T (1982) A need assessment strategy for an era of limited resources. IEA Health Unit, London
Gotzsche PC, Liberati A, Torri V, Rossetti L (1996) Beware of surrogate outcome measures. Int J Technol Assess 12:238–246
Greenland S (1996) Basic methods for sensitivity analysis of biases. Int J Epidemiol 25(6):1107–1116
Jacobs P, Bachynsky J, Baladi JF (1995) A comparative review of pharmaco-economic guidelines. Pharmacoeconomics 8:2–9
Jacobs P, Baladi JF (1996) Biases in cost measurement for economic evaluation studies in health care. Health Econ 5:525–529
Johansson M, Jonsson B (1991) Economic evaluation in health care: is there a role for cost benefit analysis? Health Policy 17:1–23
Koopmanschap MA, Rutten FFH, van Ineveld BM, van Roijen L (1995) The friction cost method for measuring indirect cost of disease. J Health Econ 14:171–89
Le Grand J, Propper C (1992) The economics of health care problems. Mac Millan Press, London
Le Grand J (1978) The distribution of public expenditure: the case of health care. Economica 45:125–42
Le Grand J (1982) The strategy of equality. Redistribution and the social services. George Allen and Unwin, London
Liss PE (1993) Health care need: meaning and measurement. Avebury, Aldershot
Luce BR, Elixhauser A (1990a) Estimating costs in the economic evaluation of medical technologies. Int J Technol Assess 6:57–75
Luce BR, Elixhauser A (1990b) Standards for socio-economic evaluation of health care products and services. Springer, Berlin Heidelberg New York
Manor O, Matthews S, Power C (1997). Comparing measures of health inequality. Soc Sci Med 45(5):761–71
Mauskopf JA, Paul JE, Grant DM, Stergachis A (1998) The role of cost-consequence analysis in healthcare decision-making. Pharmacoeconomics 13(3):277–288
Mehrez A, Gafni A (1989) Quality adjusted life years (QALYs), utility theory, and healthy years equivalent (HYE). Med Decis Making 9:142–149
Mooney G, Hall J, Donaldson C, Gerard K (1991) Utilisation as a measure of equity: weighting heat? J Health Econ 10(4):475–480
Mooney G (1987) What does equity in health mean? World Health Statistics Quarterly 4
Newmann PJ, Johannesson M (1995) From principle to public policy: using cost-effectiveness analysis. Health Affair 14:206–214
Ontario Ministry of Health (1994) Ontario guidelines for economic analysis of pharmaceutical products. Ontario Ministry of Health, Toronto
Percy-Smith J (ed) (1996) Needs assessment in public policy. Open University Press, Bristol
Petitti DB (1994) Meta-analysis, decision analysis, and cost-effectiveness analysis. Methods for quantitative synthesis in medicine. Oxford University Press, New York
Polsky D, Glick HA, Willke R, Schulman K (1997) Confidence intervals for cost-effectiveness ratios: a comparison of four methods. Health Econ 6:243–252
Popay J, Williams G (1994) Researching the people’s health. Rotledge, London
Powe NR, Griffiths RI (1995) Clinical-economic trials. In: U.S. Congress, Office of Technology Assessment. Tools for evaluating health technologies. Government Printing Office, Washington D.C.
Ried W (1998) QALYs versus HYEs—what’s right and what’s wrong: a review of the controversy. J Health Econ 17:607–625
Riegelman RK (1995) The measures of medicine. Benefits, harms, and costs. Blackwell, Cambridge, MA
Riviere R, Berkowitz S, Carter C, Ferguson CG (1996) Needs assessment: a creative and practical guide for social scientists. Taylor & Francis, London
Rovira J (1994) Standardising economic appraisal of health technology in the European community. Soc Sci Med 38:1675–1678
Rovira J (1994) The harmonisation by consensus of the methodology for economic evaluation of health technologies in the European Union. Newsletter 1, November, Barcelona
Rovira J, Antonanzas F (1994) Propuesta de estandarizacion de algunos aspectos metodologicos de los analisis coste-efectividad y coste-utilidad en la evaluacion de tecnologias y programas sanitarios. Ministerio de Sanidad y Consumo, Madrid
Russell LB, Gold MR, Siegel JE, Daniels N, Weinstein MC (1996) The role of cost-effectiveness analysis in health and medicine. J Amer Med Assoc 276(14):1172–1177
Sculpher M, Drummond M, Buxton M (1997) The iterative use of economic evaluation as part of the process of health technology assessment. J Health Serv Res Policy 2(1):26–30
Serra-Prat M, Gallo P, Jovell AJ, Aymerich M, Estrada MD (1998) Trade-offs in prenatal detection of Down syndrome. Am J Public Health 88(4):551–557
Sox HC Jr, Blatt MA, Higgins MC, Marton KI (1988) Medical decision making. Butterworths, Boston, MA
Stevens A, Raftery J (1997) Health care needs assessment. Radcliffe Medical, Oxford
Task Force on Principles for Economic Analysis of Health Care Technology (1995) Economic analysis of health care technology. A report on principles. Ann Intern Med 122:61–70
Torrance GW, Feeny D (1989) Utilities and quality-adjusted life years. Int J Technol Assess 5:559–575
Torrance GW (1986) Measurement of health state utilities for economic appraisal. A review. J Health Econ 5:1–30
Udvarhelyi SI, Colditz GA (1992) Cost-effectiveness and cost-benefit analyses in the medical literature. Ann Intern Med 116:238–244
Van Doorslaer E, Wagstaff A, Rutten F (1993) Equity in the finance and delivery of health care: an international perspective. Oxford University Press, New York
Wagstaff et al. (1999) Equity in the finance of health care: some further international comparisons. J Health Econ 18:263–290
Wagstaff A, van Doorslaer E (1992) Equity in the finance of health care: some international comparisons. J Health Econ 11:361–387
Wagstaff A, Paci P, van Doorslaer E (1991) On the measurement of inequalities in health. Soc Sci Med 33(5):545–557
Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB (1996) Recommendations of the panel on cost-effectiveness in health and medicine. J Amer Med Assoc 276(15):1253–1258
Weinstein MC (1990) Principles of cost-effective resource allocation in health care organisations. Int J Technol Assess 6:93–103